255 related articles for article (PubMed ID: 18775435)
21. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function.
Grover P; Shi H; Baumgartner M; Camacho CJ; Smithgall TE
PLoS One; 2015; 10(7):e0133590. PubMed ID: 26222440
[TBL] [Abstract][Full Text] [Related]
22. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines.
Brasher BB; Van Etten RA
J Biol Chem; 2000 Nov; 275(45):35631-7. PubMed ID: 10964922
[TBL] [Abstract][Full Text] [Related]
23. Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway.
Bassermann F; Jahn T; Miething C; Seipel P; Bai RY; Coutinho S; Tybulewicz VL; Peschel C; Duyster J
J Biol Chem; 2002 Apr; 277(14):12437-45. PubMed ID: 11790798
[TBL] [Abstract][Full Text] [Related]
24. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.
Muller AJ; Pendergast AM; Parmar K; Havlik MH; Rosenberg N; Witte ON
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3457-61. PubMed ID: 7682703
[TBL] [Abstract][Full Text] [Related]
25. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
26. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.
Glover RT; Angiolieri M; Kelly S; Monaghan DT; Wang JY; Smithgall TE; Buller AL
J Biol Chem; 2000 Apr; 275(17):12725-9. PubMed ID: 10777567
[TBL] [Abstract][Full Text] [Related]
27. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
[TBL] [Abstract][Full Text] [Related]
28. Activation of the Src family kinase Hck without SH3-linker release.
Lerner EC; Trible RP; Schiavone AP; Hochrein JM; Engen JR; Smithgall TE
J Biol Chem; 2005 Dec; 280(49):40832-7. PubMed ID: 16210316
[TBL] [Abstract][Full Text] [Related]
29. Direct analysis of the binding of the abl Src homology 2 domain to the activated epidermal growth factor receptor.
Zhu G; Decker SJ; Mayer BJ; Saltiel AR
J Biol Chem; 1993 Jan; 268(3):1775-9. PubMed ID: 7678409
[TBL] [Abstract][Full Text] [Related]
30. c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein.
Zhu J; Shore SK
Mol Cell Biol; 1996 Dec; 16(12):7054-62. PubMed ID: 8943360
[TBL] [Abstract][Full Text] [Related]
31. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
[TBL] [Abstract][Full Text] [Related]
32. c-Abl tyrosine kinase binds and phosphorylates phospholipid scramblase 1.
Sun J; Zhao J; Schwartz MA; Wang JY; Wiedmer T; Sims PJ
J Biol Chem; 2001 Aug; 276(31):28984-90. PubMed ID: 11390389
[TBL] [Abstract][Full Text] [Related]
33. Molecular and structural characterization of the SH3 domain of AHI-1 in regulation of cellular resistance of BCR-ABL(+) chronic myeloid leukemia cells to tyrosine kinase inhibitors.
Liu X; Chen M; Lobo P; An J; Grace Cheng SW; Moradian A; Morin GB; Van Petegem F; Jiang X
Proteomics; 2012 Jul; 12(13):2094-106. PubMed ID: 22623184
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the c-Abl and Bcr-Abl tyrosine kinases.
Hantschel O; Superti-Furga G
Nat Rev Mol Cell Biol; 2004 Jan; 5(1):33-44. PubMed ID: 14708008
[TBL] [Abstract][Full Text] [Related]
35. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
36. Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1.
Richard S; Yu D; Blumer KJ; Hausladen D; Olszowy MW; Connelly PA; Shaw AS
Mol Cell Biol; 1995 Jan; 15(1):186-97. PubMed ID: 7799925
[TBL] [Abstract][Full Text] [Related]
37. A potential SH3 domain-binding site in the Crk SH2 domain.
Anafi M; Rosen MK; Gish GD; Kay LE; Pawson T
J Biol Chem; 1996 Aug; 271(35):21365-74. PubMed ID: 8702917
[TBL] [Abstract][Full Text] [Related]
38. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
[TBL] [Abstract][Full Text] [Related]
39. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
Van Etten RA; Debnath J; Zhou H; Casasnovas JM
Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
[TBL] [Abstract][Full Text] [Related]
40. Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand.
Porter M; Schindler T; Kuriyan J; Miller WT
J Biol Chem; 2000 Jan; 275(4):2721-6. PubMed ID: 10644735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
